The intracellular nonlysosomal calcium-dependent cysteine protease, m-calpain, is shown to specifically cleave the bHLHzip transcription factor USF leaving the binding and dimerisation domains intact. The resultant protein is capable of efficient DNA binding but is no longer able to activate transcription. A surprisingly high proportion of other transcription factors tested, AP1 (c-Fos/c-Jun), Pit-1, Oct-1, CP1a and b, c-Myc, ATF/ CREB, AP2 and AP3 but not Sp1, were similarly cleaved by m-calpain to produce specific partial digestion products. These properties make m-calpain a particularly useful protease for proteolytic studies of transcription factors and also raise the possibility that m-calpain may be involved in vivo in regulation of turnover or transcriptional activity of a number of transcription factors.
INTRODUCTION
Sequence-specific transcription factors have been intensively studied to date for their activities in regulating the expression of genes. It is now becoming clear that post-translational modification of transcription factors, especially as exemplified by phosphorylation, can be an important part of the regulation of their activity (1) . In this paper the processing of transcription factors by the protease m-calpain is described. This raises the possibility that m-calpain may be involved in processing and turnover of transcription factors and also provides for a useful analytical tool for studying transcription factor structure and function.
Calpains are calcium-dependent nonlysosomal intracellular proteases which have been implicated in playing a mediator role in intracellular signal transduction cascades regulated by calcium (2) (3) (4) . m-Calpain (EC 3.4.22.17; calcium-activated neutral protease, CANP) is an isozyme that requires a calcium concentration of >0.2 mM for full activity in vitro and is ubiquitously expressed across species (4) . Its activity is regulated by an endogenous calpain-specific inhibitor, calpastatin, and both calpain and calpastatin are present in most tissues but at variable ratios (2) . Although active in vitro at Ca 2+ levels greatly in excess of intracellular levels, it is likely that m-calpain is activated in vivo through interactions with other proteins or co-factors. For example, autolysis of the subunits (5, 6) combined with the presence of phosphatidylinositol and/or isovalerylcarnitine (TVC) (7, 8) can decrease its Ca 2+ requirement to the micromolar level. In isolated rat liver nuclei m-calpain was found to reach half maximal activity at 3 \M. Ca 2+ (9) . Intracytosol Ca 2+ levels vary between 0.1 /tM at a resting state to the micromolar level upon transient discharge of intracellular calcium stores in response to cellular or extracellular signals (10) . It has been shown by subcellular fractionation studies that m-calpain associates with subcellular organelles including the nuclear fraction (11) , and by Western transfer and immunolocalization low levels are detected in the nuclear membrane and nucleoplasm (12) . Differential distribution of m-calpain during cell cycle, including localisation to mitotic chromosomes, was also demonstrated by immuno-microscopy (13, 14) .
Calpain has a narrow substrate specificity and most of its known substrates have been identified from in vitro studies. These include structural proteins (membrane and cytoskeleton components, myofibrillar proteins), enzymes (several kinases) and hormone receptors (4, 15) . Unlike most proteases which result in extensive degradation of proteins, calpain, which seems to recognize the overall conformation of substrate proteins, usually produces large limited-proteolytic fragments cleaved in the vicinity of the boundary of two domains (15) (16) (17) . A protein destabilising sequence, enriched with the amino acids, proline, glutamic acid/aspartic acid and serine/threonine, P,D/E,S/T or 'PEST', in combination with structural features may be involved in substrate recognition by calpains (15, 18, 19) . This property is important since it can cause functional changes of substrates into active or inactive forms. For example, m-and ^-calpain convert to constitutively active forms protein kinase C (Ca 2+ /phospholipid/phorbol ester-independent) and CaM kinase II (Ca 2+ /calmodulin-independent). Therefore, a role for calpains in signal transduction has been proposed (20) (21) (22) (23) .
We demonstrate that a number of transcription factors, including the c-Myc and c-Fos proteins which are characterised by high turnover rates and the presence of PEST regions (18, 19) , are substrates for m-calpain. During the progress of this work it was also reported by Hirai et al. (24) that calpains could regulate the activity of the c-Fos and c-Jun proteins in vivo.
MATERIALS AND METHODS

Preparation of whole cell and nuclear extracts, and partial purification of transcription factors
Whole cell extracts of HeLa cells and nuclear extracts of Hela, HepG2, GC and F9 cells were made by the methods of Manley et al. (25) and Shapiro et al. (26) respectively. The GC cell nuclear extract and F9 cell nuclear extract were kind gifts of D. Catanzaro and M. Frommer. Nuclear extract was dialysed against Buffer A-0.1 containing 0.2 mM EGTA: Buffer A-0.1 is Buffer A [20 mM HEPES-KOH (pH 7.9), 20% glycerol (vol/vol), 1 mM EDTA, 2 mM DTT, 0.5 mM PMSF] containing 0.1 M KC1. Protein concentrations of the HeLa extracts were = 20 mg/ml for whole cell extract and = 10 mg/ml for nuclear extract. HeLa whole cell extract was partially purified by successive chromatography essentially as described (27) . The USF containing subfractions, A (2 mg/ml), AA (1.25 mg/ml protein) and AB (3.25 mg/ml protein), were the P-11 phosphocellulose flowthrough, the successive flowthrough fractions from P-l 1 and DEAE-sephacel columns and the 0.35 M KC1 eluate from DEAEsephacel column, respectively (28) . For other transcription factors, partially purified HeLa whole cell extract fractions were used: PI 1 flowthrough (Fraction A) for Oct-1 as suggested in the method (29) , DE-52 flowthrough (Fraction Cl) of the 0.5 M KC1 eluate from P-ll for ATF and CPlb as suggested by (30, 31) , and Fraction AB for CPla as suggested by (31) . The Spl containing fraction was the peak fraction from 0.3 M KC1 elution step of heparin agarose column and dialysed against TM-0.1 strictly as described (32) . The presence of above factors were confirmed by electrophoretic mobility-shift assay (EMSA). A bacterially-expressed recombinant form of human USF (rUSF, 43 kD) and its derivative, short USF (shUSF), were prepared by expressing the plasmids pET3dUSF and pET3dshUSF (A 1 -196) respectively (kind gifts of R. Roeder) and purified by heparin agarose and DEAE dextran chromatography essentially as described (33, 34) . In vitro transcription and translation were performed using TNT™ kit (Promega Biotech) under conditions essentially as recommended by the supplier. Cold and labelled proteins were produced from each of the following plasmids: pSP65-c-fos (c-Fos) and pSP65-c-jun (c-Jun) (kind gifts from D. Cohen), and pBSO/lmyc (c-Myc) and pVZ21p21 (Max) (kind gifts of R. Eisenman).
Preparation of oligonucleotides and DNA restriction fragments (i) A 126 bp restriction fragment of the adenovirus 2 major late promoter (AdMLP) was prepared by digestion with Avail and Hhal. For the Oct-1 recognition sequence, an 80 bp EcoKlHindHl restriction fragment was cleaved from pUCl 19B20 (35) (a kind gift of R. Sturm), (ii) The following double-stranded synthetic oligonucleotides were labelled and gel-purified as described (36) : for the USF site of the Ad2MLP (100-mer and 23-mer) (36) , the Spl sites of the SV40 promoter (5'-CTAGA-ATTCGAGCTCACCCGGGTAGGATCCTACTCCGCCCA-TAACTCCGCCCAGGAATTCACTGCAGTGTCGACTCTA-GACC-3') (37), the Pit-1 site of the rat growth hormone gene promoter (5'-AATTCGATTATATATATATTCATGAAGGT-GTCGAATT-3') (38) (kindly provided by D. Catanzaro), the ATF site of the Ad5EIIaE promoter (5'-GGCCGCTGGAGAT-GACGTAGTTTTCGCG-3') (39), the CP1 site of the Ad2MLP (5 '-TCTTCGGCATCAAGGAAGGTGATTGGTTTTAGGTG-TAGG-3') (31), and the AP-1 site of the human metallothionein HA promoter (5'-GATCCGGCTGACTAATCAAGCTGAT-C-3') (40) (provided kindly by M. Sleigh).
Electrophoretic mobility-shift assays (EMSA) and protease digestions Standard reactions (20 jtl) contained 4-10 fmoles of labelled DNA fragment, 0.5-2 ng of poly(dI-dC) (dl-dC), and 3-12 /*1 of the protein-containing fraction. The final buffer conditions were the Buffer-0.06 [12 mM HEPES-KOH (pH 7.9), 60 mM KC1, 5 mM MgCl 2 , 0.6 mM EDTA, 1.2 mM DTT, 2 /ig BSA (BRL), 0.05% NP-40], with or without 5 mM CaCl 2 . Reactions were pre-incubated for 10 min at 30°C prior to addition of the labelled probe, unless specified, with further incubation for 40 to 60 min. Calpain digestion was carried out during the last part of the incubation; for example, for a 5 min calpain digestion in a 60 min binding reaction CaCl 2 and m-calpain (0.025 units) were added after 55 min. Reactions containing 5 mM CaCl 2 but no added m-calpain were set as controls for endogenous protease activity. Proteases used for comparison were trypsin (62 units), V8 (0.1 unit) and papain (0.1 unit). The concentrations of protease inhibitors used were; 5 mM EGTA, 1 mM benzamidine, 1 mM PMSF, 10 mM iodoacetamide (IAM), 0.2 mM antipain, 4 mM chymostatin, 4 mM leupeptin and 250 jig/ml soybean trypsin inhibitor. The proteases and protease inhibitors were purchased from Sigma. For Spl binding, the standard reaction mixture was modified; 500 ng E.coli DNA replaced poly (dl-dC) as carrier DNA, KC1 and ZnSO 4 were added to 50 mM and 2 mM respectively. Protein-DNA complexes were analyzed subsequently by electrophoresis as described (28) .
In vitro transcription assay
Templates for in vitro transcription were plasmids pAdML-CAT and pSVEnless-CAT (41) . CAT-primer (kindly provided by H. Drew) for primer extension was a synthetic single-stranded 25 nucleotide primer which hybridises to sequences from +47 to +71 relative to the HindHl site near the beginning of the CAT RNA start site.
USF-depleted whole cell extract was prepared by mixing 50 /tl HeLa whole cell extract (ca. 20 mg/ml) with 1.25 ng each of poly(dl-dC) (dl-dC) and pUC18 in a 96 *tl reaction in Buffer A containing 60 mM KC1 and 0.05% NP40 and incubated for 10 min at 30°C. Pre-equilibrated USF oligo affinity resin (54 n\) (36) was then added and incubated for 2 h at 30°C. The removal of USF was monitored by EMSA of samples taken before and after the resin treatment. m-Calpain treatment of USF in nuclear extract was done by adding m-calpain (0.025 unit) to 1 jil HeLa nuclear extract (10 mg/ml) in 22 jtl of Buffer A containing 60 mM KC1 and 5 mM CaCl 2 and incubating for 5 to 60 min at 30°C. The digestion was stopped by addition of EGTA to 10 mM. A control reaction without added m-calpain was incubated for 60 min.
In vitro transcription reactions (40 jd) contained template DNAs (600 ng pAdMLP-CAT and 400 ng pSVEnless-CAT), 12 pi of USF-depleted whole cell extract (or 4 pi untreated extract) and 22 |tl of m-calpain treated or control nuclear extract as the source of USF, and the following buffer components: 375 pM nucleoside triphosphates, 5 mM creatine phosphate, 8 pg creatine kinase, 5 mM MgCl 2 , 0.5 unit RNAsin (Promega), 12 mM HEPES-KOH (pH 7.9), 0.6 mM EDTA, 0.6 mM DTT, 12% glycerol and 50 mM KC1. Reactions were incubated for 1 h at 30°C, and stopped by adding 100 p\ Proteinase K-Stop Buffer, containing 200 ng proteinase K, 0.5% SDS, 25 mM Tris-HCl (pH 7.5), 10 mM EDTA and 100 /tg tRNA. Proteinase K digestion was carried out at 37 °C for 30 min, followed by extraction with phenol:chloroform (1:1), and adjusted to 0.3 M NaOAc for ethanol precipitation. After ethanol precipitation, pellets were rinsed with 70% ethanol and vacuum dried. Primer extension analysis was as described by Jones et 
Protein analysis on SDS-PAGE
Protein samples were precipitated by adding five volumes of icecold acetone, dried and re-dissolved in sample buffer and analysed by SDS-PAGE as described by Laemmli (43). Pre-stained molecular weight markers (BRL) were used for size calibration.
RESULTS
Calcium-dependent proteolytic modification of USF
During experiments using EMSA to examine the effects of different metal ions on binding of USF, we noted that in the presence of Ca 2+ a faster migrating complex was formed on an AdMLP fragment. This complex was predominant in the AB chromatographic fraction of a HeLa whole cell extract [flowthrough from a Pll phosphocellulose column subsequently eluted at 0.35M KC1 from a DEAE-sephacel column, according to the fractionation scheme of Samuels etal. (27) ]. Footprinting experiments on the AdMLP and growth hormone promoters indicated protection of the same region as USF but with a slight shortening of the protected region. Further chromatographic fractionation on heparin-agarose demonstrated separation of USF from a Ca 2+ -dependent activity which acted on USF to produce the faster-migrating complex. The experiments described below led to the conclusion that this activity was the calcium-dependent protease m-calpain. Titration assays were carried out to determine the minimum calcium concentration required for formation of the faster migrating complex (CII). As Figure 1A shows, digestion of the USF complex (CI) began at calcium concentrations from 0.1 mM with the clear predominance of CII at 0.4 mM CaCl 2 and the presence of intermediate complexes at lower CaCl2 concentrations.
In order to demonstrate that CII was a proteolytic product of CI and to identify the type of protease responsible for this effect, a number of protease inhibitors were tested ( Figure IB ). Shifts to CII were prevented by the calcium chelator, EGTA, and by the cysteine (thiol) protease inhibitors, iodoacetamide, and leupeptin as well as by a papain inhibitor (lane 7) but not by serine and trypsin protease inhibitors (lanes 4, 5, 8 and 10). The result indeed confirmed that a calcium-dependent protease was responsible for the appearance of CII through limited proteolysis of USF. The type of inhibitors which were effective, and particularly the limited proteolysis which maintained the DNAbinding domain of USF, suggested that the protease activity detected was m-calpain, a calcium-activated cysteine (neutral) protease. The chromatographic profile of the protease activity over DEAE-sephacel, heparin-agarose and thiol sepharose columns was found to be the same as that described for m-calpain and not /i-calpain, the isozyme active at low Ca 2 + concentrations, which separates from m-calpain into the flowthrough at DEAE column step (44) (results not shown). In the course of this work, commercially prepared m-calpain from rabbit skeletal muscle (mCANP, Sigma) became available and it was shown to have identical activity to that identified in our HeLa extracts (Figure 2 ). 
Digestion of USF with m-calpain and other proteases
The commercial m-calpain prepared from rabbit skeletal muscle was compared with the endogenous activity in fraction AB and also with activities of V8 protease, papain and trypsin ( Figure  2 ). Both V8 and trypsin are serine proteases whilst papain is a cysteine protease, but all three are calcium-independent. Commercially prepared m-calpain produced a digestion profile identical to the endogenous protease (lanes 2-6). Limited digestion by V8 protease, papain and trypsin generated protein-DNA complexes having slightly different mobilities. Thus, these four proteases can truncate USF at slightly different sites while initially preserving the DNA binding and dimerisation domains, as seen by intermediate complexes with different mobilities. However, in contrast to m-calpain, longer digestion with these proteases led to the complete disappearance of these fastermigrating complexes (results shown for trypsin only).
Narrow substrate specificity of m-calpain shown by SDS-PAGE
The extent of general proteolytic degradation caused by m-calpain under conditions used for EMSA studies was assessed. Under conditions which lead to conversion to the faster migrating USF-DNA complex it is clear, despite the limited resolution achieved by one-dimensional SDS PAGE, that the overall protein profile of fraction AB (Figure 3) or AA (not shown) was virtually unchanged. Only a limited number of proteins could be identified as m-calpain substrates (since their disappearance was prevented by IAM but not by serine protease inhibitors (lanes 6-8) ). By comparison, under digestion conditions for V8 protease and papain where truncated protein-DNA complexes were seen (Figure 2) , extensive proteolysis to a dominant band of about 30 kD and a lower molecular weight smear (<20 kD) was evident (data not shown). 
Determination of the size of truncated USF
To characterise the proteolytically truncated USF, the size determination was conducted with bacterially expressed and purified 43 kD type USF (amino acids, 1-311) (33) . SDS-PA-GE analysis revealed that m-calpain generated multiple intermediates including three major peptides, 'a', 'b' and 'c' with apparent molecular masses, 18.5, 16.5 and 14.5 kD, respectively ( Figure 4A, lanes 5-7) . The relative amounts of peptides 'a' and 'b' were increased in the presence of USF oligonucleotide (lane 8), suggesting that these peptides contain the DNA-binding domain. The product 'b' was only slightly larger than the bacterially expressed 'short USF' (=15.5 kD, shUSF) which contains the C-terminal amino acids 196-311 of 43 kD USF (34) . The smallest peptide 'c' was also generated from the shUSF (lane 10). Clipping of bacterially expressed 43 kD USF at multiple sites by m-calpain was also shown by EMSA ( Figure  4B , lane 6). The DNA-protein complex of fastest mobility generated from 43 kD USF (lane 8) migrated slightly behind the complex formed by shUSF (lane 9), suggesting that this final product was equivalent to the 16.5 kD peptide.
The effect of proteolytically-truncated USF on transcription
The effect of truncated USF on transcription was studied in vitro using pAdML-CAT ( Figure 5B ) and as a control template pSVErdess-CAT which does not have a binding site for USF and whose transcription is independent of the presence of USF. A whole cell transcription lysate was depleted of USF by two cycles of USF-oligonucleotide affinity treatment. Specific removal of USF was demonstrated by the substantial loss of transcription from the AdMLP while transcription from the SV40 early promoter was essentially unaffected (compare lanes 1 and 4, Figure 5A ). USF was provided as a supplement of a nuclear extract, which alone showed very low transcription activity (lane 2) but when combined with whole cell extract restored transcription from the AdMLP with little effect on the SV40 early promoter (lane 5). Treatment with m-calpain of the supplementary nuclear extract for times up to 30 min progressively reduced the transcription signal from the AdMLP with minimal effect on the SV40 early promoter. In the presence of added Ca 2+ , endogenous calpain in the nuclear extract also reduced transcription from the AdMLP, though not as efficiently as added m-calpain.
The differences between lanes 5 and 7, and also between lanes 6 and 9, suggest that the truncation of USF, by calpain treatment of the supplementary nuclear extract, was primarily responsible for the decreased transcription. Because the truncated USF could still bind to the USF element, the absence of transcription implies that the proteolysis removed a transcriptional activation domain from USF. In contrast, the transcription signals from pSVEnless-CAT, SV40 (I) and other initiation sites [e.g. SV40 (II)], were consistently at the same level under different conditions (lanes 2 to 9). The results indicate that the effect of calpain was specific to the AdMLP template and that the lack of transcription was not due to the interference caused by possible proteolytic modification of general transcription factors (including TFTID) in the nuclear extract. Such interference should have equally affected the assembly of a transcription apparatus on the SV40 template despite the intact components present in whole cell extract.
Susceptibility of other transcription factors to m-calpain
When this investigation started, no transcription factors were known to be m-calpain substrates except steroid hormone receptors (45, 46) . Since m-calpain has a narrow substrate specificity, we wished to determine whether other transcription factors are substrates for limited proteolysis by m-calpain and to assess if there are any common structures or functions shared between them that can be related to the findings with USF. Eight known transcription factors were examined, either using EMSA with oligonucleotides containing their recognition sequences or by direct visualisation of proteolytic modification using SDS-PAGE (Figures 6 and 7) . With the exception of one factor, Spl, seven other factors were found to be substrates of m-calpain. The factors Pit-1 and ATF were digested with similar kinetics as USF and also produced truncated products which retained DNA binding activity and were relatively resistant to further mcalpain digestion. Digestion of the factors, CP1, Oct-1 and in vitro translated c-Fos/c-Jun complex (AP-1, Figures 6 and 7) and also AP2 and AP3 (data not shown) gave rise to truncated products with DNA binding activity, but for these proteins continued digestion led more readily to a loss of DNA binding. In contrast to m-calpain, trypsin, whose activity was adjusted to produce limited proteolysis, digested progressively the transcription factors ATF, Oct-1, CP1 and AP2 and 3, and even Spl was digested away by 5 min (data not shown except ATF and Oct-1, Figure 6 ). m-Calpain was also found to cleave both subunits of the C-AAT box binding factor, CP1 (Figure 6 ). CP1 is a hetero- multimer containing two chromatographically separable subunits, CPla and CPlb, both of which are required for DNA binding activity (31) . Each subunit separately showed susceptibility to m-calpain and could form a complex of increased mobility with the intact other subunit. Digestion of both subunits together for an equivalent time resulted in a complete loss of DNA binding. This could reflect a faster rate of degradation of the dimerised subunits, or poorer dimerisation or protein-DNA complex formation when both have been cleaved. Results obtained by EMSA were extended by studying the susceptibility to m-calpain of the in vitro translated protooncogene products, c-Fos and c-Myc alone or in combination with their heterodimer partners, c-Jun and Max respectively. As expected from the EMSA results c-Fos present in c-Fos/c-Jun heterodimers was cleaved by calpain to produce major intermediate digestion products which were further degraded upon longer incubation. In the absence of c-Jun digestion of c-Fos was much more rapid ( Figure 7A, lanes 4-9) . The poor ability of c-Fos to form homodimers may mean that m-calpain cleavage sites protected upon dimerisation are more available for cleavage than when c-Jun is present for dimerisation. The bHLHzip protein c-Myc is closely related structurally and in its DNA-binding specificity to USF (47) . It proved to be more highly susceptible than USF to m-calpain and intermediate digestion products seen at short digestion times disappear upon further digestion ( Figure  7B, lanes 8 and 9) . The level of m-calpain used in for cleavage of c-Myc was 0.05 units for up to 2.5 min compared to 0.1 unit for up to 60 min for USF (see Figure 2) . In the presence of its heterodimer partner, Max, the sensitivity of c-Myc to m-calpain is not altered significantly.
DISCUSSION
The work presented here demonstrates that: (1) USF and a number of other transcription factors are substrates for the calcium-dependent neutral protease, m-calpain; (2) proteolytic fragments generated from the substrate transcription factors upon limited or extensive digestion by m-calpain can retain the ability to bind to their DNA target sites; (3) the product from limited proteolysis of USF retains specific DNA-binding ability but is not able to stimulate transcription from the AdMLP in vitro. The possible significance of these results for in vivo function as well as their application for in vitro analysis of transcription factors are discussed below.
Limited proteolysis by calpain: a useful tool for structural studies of functional domains of transcription factors
Despite its narrow substrate specificity, all but one of transcription factors tested were found to be substrates of m-calpain. Previously steroid hormone receptors and c-Fos and c-Jun have been shown to be substrates for m-calpain (24). All generated as major intermediates of digestion, calpain-resistant DNA-binding 'cores' which retained their ability for sequence-specific DNA binding and formed faster migrating DNA-protein complexes which were stable to EMSA; in the case of some factors, USF, ATF and Pit-1, the DNA binding domains were substantially resistant to further m-calpain digestion. These resistant 'cores' include characteristic motifs for DNA binding, the bHLH-LZ motif (USF and c-Myc), the bLZ motif (ATF, c-Fos) and the POU-domain (Pit-1 and Oct-1) (47) (48) (49) (50) (51) . The results are consistent with the known propensity of m-calpain to cleave proteins in hinge regions between domains but not within the domains; therefore, m-calpain is suitable for dissecting functional domains of transcription factors required for sequence-specific DNA binding. m-Calpain may also be used to distinguish subtle structural differences between the family of proteins containing the same DNA binding motif, as shown between the proteolytic profiles of Pit-1 and Oct-1, which both contain the POU-domain. Since amino acid sequences within the motif are highly conserved between these two factors (51, 52) , the difference in the proteolytic profile between them was possibly due to the presence of calpain susceptible site(s) within or very close to the POU-domain of Oct-1. Three potential targets enriched in the amino acids 'P,E/D,S/T', possibly forming a PEST sequence, are located adjacent to this domain in Oct-1 but are absent from the corresponding regions of Pit-1. The combined features of a PEST sequence and a boundary of domains could make a good target site for calpain cleavage.
Recendy a number of papers have been published which examine functional domains of transcription factors by a combination of proteolysis and DNA-binding assays. The
Sp1
Pit-1 presence of DNA-binding, protease-resistant 'cores' in human TFHD (53), herpes simplex virus Vmwl75 (54) and murine a-CP1 (55) was demonstrated using trypsin and/or V8 proteases. However, proteolysis with endoproteases had to be controlled carefully to achieve conditions that generate a 'protease-resistant core', the products of partial digestion. We have found that digestion by m-calpain is more readily controlled and it has the significant advantage that digestion can be efficiently stopped by addition of EGTA, permitting further analysis of the proteolytic products without separation from the protease.
The possible function of the calpain-truncated USF was examined by in vitro transcription using the AdMLP as a template. The specific suppression of transcription was shown to be dependent on calpain treatment of the USF supplement, suggesting that the truncated USF without the activation domain acted as a repressor by simply occupying its recognition site. Other studies have shown that the 'protease resistant core' of a-CP1 (55) also binds DNA but does not activate transcription while the 'core' of 1'hilL) was determined to be equally active as native TFIID in basal level transcription in vitro (53 
Biological implications of calpain proteolysis of transcription factors
The properties of m-calpain suggest that it may be involved in turnover of transcription factors. Products of a number of nuclear oncogenes, including c-myc and c-fos shown here to be m-calpain substrates, have very short half lives in vivo and their mode of degradation is unknown. It has been suggested that the ubiquitin pathway may be involved in selective destruction of unwanted nuclear oncoproteins (56, 57) . However, the transcription factors studied here do not have the so-called 'destruction sequence' required for recognition by the ubiquitin system and this pathway invariably degrades a substrate completely (56, 58) . In the case of c-Myc, proteolytic turnover in vivo has been studied and it does not involve the ubiquitin pathway or lysosomal enzymes; however, specific intermediate proteolytic degradation products which might be indicative of calpain action were not detected (59) .
It is also conceivable that, if calpain proteolysis of transcription factors occurs, it may not be a simple process of degradation; limited proteolysis may be involved in modulation of the activity of transcription factors. By directly binding its cognate site or interfering with the activity of the intact protein by forming a dimer, a truncated factor may modulate regulation of target gene transcription in a manner similar to the recently discovered small transcription factors which lack an activation domain, e.g. Id and Max (60, 61) .
The most direct evidence for a role for calpain in regulation of gene expression comes from experiments in which the level of its specific inhibitor, calpastatin, was modulated in vivo. Hirai et al. (24) demonstrated that the co-expression of exogenous cJun cDNA with calpastatin sense and anti-sense cDNA affected an increase and a decrease, respectively, of c-Jun-dependent expression of the TRE-tk-CAT gene in NIH3T3 and F9 cells, indicating that inhibition of m-calpain activity may enhance the stability and activity of c-Jun.
A number of pieces of circumstantial evidence support the possibility that m-calpain is involved in transcription factor regulation or turnover. The presence of m-calpain in the nucleus has been demonstrated by sub-cellular fractionation and by immunolocalization (12) and a calcium-dependent protease activity has been demonstrated in rat liver nuclear matrix preparations (62) . A stage-specific association with chromosomes during mitosis in PtKl cells has also been demonstrated (13) although it was not reproducible in other cell types (14) . The environment of the cell nucleus appears to be particularly favourable for m-calpain action. The enzyme is capable of cleaving and releasing proteins from isolated nuclei at concentrations of Ca 2+ in the range of 10~5 to 10~6 M (63). This proteolysis had a requirement for DNA as a co-factor and appeared to involve a complex of DNA nuclear matrix components and m-calpain (64). Histone HI was also shown to reduce it to 10~5 M Ca 2+ and to promote limit proteolysis by m-calpain of the active form of PKC (65) . These observations and the demonstrated involvement of m-calpain in cleavage of c-Mos during the meiotic cell-cycle in Xenopus (66) are indicative of an important role for m-calpain in metabolism of nuclear proteins.
